VIVEVE MED INC's ticker is VIVE and the CUSIP is 92852W204. A total of 11 filers reported holding VIVEVE MED INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $1,437,000 | +16.9% | 200,132 | +3.1% | 0.57% | +57.3% |
Q1 2017 | $1,229,000 | +52.1% | 194,132 | +23.7% | 0.36% | +22.6% |
Q4 2016 | $808,000 | -64.3% | 156,899 | -49.9% | 0.30% | -56.9% |
Q3 2016 | $2,262,000 | +49.5% | 313,308 | -15.1% | 0.69% | +6.8% |
Q2 2016 | $1,513,000 | – | 368,919 | – | 0.64% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 3,849,711 | $10,471,000 | 6.36% |
RTW INVESTMENTS, LP | 2,861,023 | $7,782,000 | 0.56% |
Nantahala Capital Management | 3,948,132 | $10,739,000 | 0.44% |
Granahan Investment Management | 792,607 | $2,156,000 | 0.13% |
ACUTA CAPITAL PARTNERS, LLC | 267,500 | $728,000 | 0.13% |
KNOTT DAVID M | 71,449 | $194,000 | 0.07% |
WEXFORD CAPITAL LP | 349,100 | $950,000 | 0.06% |
HighTower Advisors, LLC | 1,821,456 | $4,957,000 | 0.04% |
MEITAV INVESTMENT HOUSE LTD | 310,000 | $800,000 | 0.04% |
J. Goldman & Co LP | 221,000 | $601,000 | 0.03% |